Brainstorm Cell Therapeutics Inc. Gains 32.61%

Wed, Mar 29, 2023 at 07:03 PM
Brainstorm Cell Therapeutics Inc. Gains 32.61%

Brainstorm Cell Therapeutics Inc. (BCLI:NASDAQ) jumped higher at $2.44, a gain of 32.6%. On Wed, Mar 29, 2023, BCLI:NASDAQ touched a New 2-Week High of $2.44. The stock got featured on our News Catalysts scanner on Mon, Mar 27, 2023 at 02:37 PM in the 'BIOTECH' category. From Wed, Mar 15, 2023, the stock recorded 60.00% Up Days and 54.55% Green Days

About Brainstorm Cell Therapeutics Inc. (BCLI:NASDAQ)

Brainstorm Cell Therapeutics Inc is a biotechnology company. The Company develops novel adult stem cell therapies for debilitating neurodegenerative disorders such as ALS, MS, and PD among others.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.